Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 22, 2013, 08:30 ET
Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver a corporate update at the Jefferies 2013 Healthcare Conference taking place...
More news about: Rosetta Genomics Ltd. , Jefferies 2013 Healthcare Conference
-
May 20, 2013, 12:48 ET
Rosetta Builds on Commerce Momentum as Platinum Sponsor at IBM Smarter Commerce Global Summit
Rosetta, a leading customer engagement agency and independent brand in the Publicis Groupe, is building on its run of new Commerce assignments with the Platinum Sponsorship of the IBM Smarter Commerce Global Summit 2013, which begins Tuesday, May 21 and runs through Thursday, May 23 in...
More news about: Rosetta , Publicis Groupe , IBM Smarter Commerce Global Summit 2013 , IBM
-
May 20, 2013, 08:30 ET
Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has executed a credentialing agreement with Prime Health Services, Inc. (Prime Health), a managed care company that offers a full spectrum of services,...
More news about: Rosetta Genomics Ltd. , Prime Health Services, Inc.
-
May 14, 2013, 16:10 ET
Comstock Resources, Inc. Announces Closing of West Texas Divestiture
Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE: CRK) announced that it has completed the divestiture of its West Texas operations with the closing of the sale of its oil and gas properties in Reeves and Gaines counties in West Texas to Rosetta Resources Inc. (NASDAQ: ROSE)....
More news about: Comstock Resources, Inc. , Rosetta Resources Inc.
-
May 10, 2013, 08:30 ET
Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of $625,000 as payment in full from the negotiated settlement announced on April 18, 2013 with Sanra Laboratories (Sanra) in connection with the Company's sale to...
More news about: Rosetta Genomics Ltd. , Sanra Laboratories , Parkway Clinical Laboratories
-
May 08, 2013, 09:31 ET
Critical Alerts For Oracle, DirecTV, Urban Outfitters, American Axle & Manufacturing, and Rosetta Resources Released By InvestorsObserver
InvestorsObserver issues critical PriceWatch Alerts for ORCL, DTV, URBN, AXL, and ROSE. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch...
More news about: InvestorsObserver , Oracle , DirecTV , Urban Outfitters , American Axle & Manufacturing , Rosetta Resources
-
May 07, 2013, 08:30 ET
Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announces that the Company's miRview® suite of oncology diagnostic assays will be highlighted in an "Industry Expert Theater Presentation" at the American Society of...
More news about: Rosetta Genomics, Ltd.
-
Apr 18, 2013, 09:00 ET
Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the Company has negotiated a settlement with Sanra Laboratories ("Sanra") in connection with the previous sale of Parkway Clinical Laboratories ("Parkway") by...
More news about: Rosetta Genomics Ltd. , Sanra Laboratories , Parkway Clinical Laboratories
-
Apr 17, 2013, 13:10 ET
Rosetta Announces Opening of New West Coast Headquarters Building in San Luis Obispo
Rosetta, a Publicis Groupe company, today announced the opening of its new West Coast headquarters office with the completion of a 48,000-square-foot building in San Luis Obispo. The LEED-certified two-story building will house 150 current team members of the interactive agency with capacity to...
More news about: Rosetta , Publicis Groupe
-
Apr 03, 2013, 12:39 ET
Four Industry Veterans Join Rosetta's Technology and Telecommunications Vertical
Rosetta, an independent brand in the Publicis Groupe of global agencies and one of the nation's largest digital and direct interactive agencies, today announced it has hired four new Partners to support the rapid growth of its Technology and Telecommunications Vertical, the agency's fastest...
More news about: Rosetta , Publicis Groupe
-
Apr 02, 2013, 09:56 ET
Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that two posters related to the Company's microRNA-based diagnostic assays will be featured at the American Association for Cancer Research (AACR) Annual Meeting 2013, to be...
More news about: Rosetta Genomics Ltd.
-
Apr 01, 2013, 08:00 ET
Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a manuscript regarding the development and validation of the Company's microRNA-based diagnostic assay for the classification of renal cell tumors has been accepted...
More news about: Rosetta Genomics Ltd.
-
Mar 25, 2013, 08:30 ET
Rosetta Genomics To Host Business Update Conference Call on April 10, 2013
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that following the close of the U.S. stock market on Friday, March 22, 2013, the Company filed its Annual Report on Form 20-F for the year ended December 31, 2012...
More news about: Rosetta Genomics Ltd.
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |